Demo-Umgebung · Gesundheitsdaten sind synthetisch · Studien und laufende Trials sind echt (Europe PMC · ClinicalTrials.gov)
VITA LONGA Longevity Intelligence
Anmelden
Frühstück mit Haferflocken, Beeren und Wasserglas auf Holztisch am Fenster im Morgenlicht

Intervallfasten: Effekt oder Kalorienreduktion?

Kontrollierte Vergleiche zeigen ein nüchterneres Bild als die öffentliche Debatte.

Time-restricted Eating verbessert in vielen Studien Gewicht, Nüchternglukose und Blutdruck. Die entscheidende Frage ist, ob das ein eigenständiger Effekt des Essensfensters ist oder schlicht Folge geringerer Kalorienzufuhr.

Weniger Kalorien als Hauptmechanismus

Studien, die die Kalorienzufuhr zwischen den Gruppen angleichen, finden meist deutlich kleinere Zusatzeffekte. Der Hauptmechanismus scheint zu sein, dass ein enges Essensfenster die spontane Kalorienzufuhr senkt – was praktisch nützlich, aber theoretisch weniger spektakulär ist.

Frühes Essensfenster bei Glukose im Vorteil

Interessanter als der Gewichtseffekt ist die zirkadiane Komponente: Ein Essensfenster, das früher am Tag liegt, schneidet in mehreren Untersuchungen bei Glukosetoleranz besser ab als dasselbe Fenster am Abend.

Kernaussagen

  • Ein Großteil des Effekts erklärt sich über reduzierte Kalorienzufuhr.
  • Ein früher liegendes Essensfenster schlägt dasselbe Fenster am Abend.
  • Als Adhärenz-Werkzeug nützlich, als eigenständiger Mechanismus überschätzt.

Mehr zum Thema

Vertiefen Wirkt Intervallfasten auch auf Entzündungen, etwa bei Rheuma? Einige Studien fanden günstigere Entzündungs- und Stressmarker, die Belege sind aber dünn. · 2 Min. Nächster Schritt 16:8, 5:2 oder jeden zweiten Tag fasten – welche Form passt zu meinem Alltag? Die drei Formen im Vergleich nach Ablauf, Aufwand und Alltagstauglichkeit. · 4 Min. Querverbindung Wie viel Protein pro Mahlzeit brauche ich beim Intervallfasten für die Muskeln? Proteinmenge pro Mahlzeit, Leucin und Timing für den Muskelaufbau. · 3 Min.

Belege (3)

Open-Access-Publikationen mit offener Lizenz, direkt verlinkt.

The Effectiveness of Time-Restricted Eating as an Intermittent Fasting Approach on Shift Workers' Glucose Metabolism: A Systematic Review and Meta-Analysis

●●●●● Nutrients·2025· 4 Zitationen· cc by Original ↗
Abstract

<b>Background/Objectives</b>: Shift workers face higher risks of impaired glucose metabolism due to irregular eating habits and circadian misalignment. Time-restricted eating (TRE) could improve glucose metabolism by aligning food intake with the circadian clock, but its effectiveness remains unclear. <b>Methods</b>: Ten electronic databases (PubMed, EMBASE, Cochrane Library, CINAHL, PsycINFO, Scopus, Web of Science, ProQuest Dissertations and Theses, Science.gov, and ClinicalTrials.gov) were searched from journal inception to September 2024. Only randomized controlled trials (RCTs) involving shift workers were included. Meta-analyses with sensitivity analyses were conducted using a random-effects model to pool glucose metabolism and sleep outcomes, with heterogeneity and quality assessments performed. <b>Results</b>: Six RCTs were included. TRE demonstrated positive but non-significant effects on glucose metabolism outcomes: fasting blood glucose (weighted mean difference [WMD]: -0.02 mmol/L, 95% confidence interval [CI]: -0.13 to 0.10, <i>I</i><sup>2</sup> = 0%), fasting blood insulin (WMD: -5.77 pmol/L, 95% CI: -85.62 to 74.08, <i>I</i><sup>2</sup> = 92%), HOMA-IR (WMD: -0.50, 95% CI: -2.76 to 1.76, <i>I</i><sup>2</sup> = 82%), 2 h postprandial glucose (WMD: -0.65 mmol/L, 95% CI: -3.18 to 1.89, <i>I</i><sup>2</sup> = 86%), total sleep time (<i>g</i> = 0.07, 95% CI: -0.23 to 0.37, <i>I</i><sup>2</sup> = 0%), and sleep efficiency (<i>g</i> = -0.05, 95% CI: -0.63 to 0.53, <i>

Time restricted EAting for Type 2 diabetes and MEtabolic health: The TEA TIME trial study protocol

●●●●○ PloS one·2026· 1 Zitationen· cc by Original ↗
Abstract

<h4>Background</h4>Recent findings have suggested that implementing the emerging weight-loss strategy of time-restricted eating (TRE) for 6 weeks can have beneficial effects on the key pathophysiologic determinants of type 2 diabetes (T2DM) - namely, pancreatic beta-cell function and insulin resistance. Given the chronic nature of T2DM and the general challenge of long-term adherence to dietary interventions, a critical question is the durability of such effects. Specifically, we seek to determine whether TRE can improve the metabolic health of patients with T2DM over 1 year.<h4>Methods</h4>In this open-label, parallel-arm, randomized controlled trial, individuals with overweight/obesity and T2DM of <10 years duration will be randomized to either standard lifestyle recommendations or TRE. The TRE protocol will consist of 18 hours of fasting and a 6 hour window of eating (between 2-8 PM) each day. The duration of the intervention will be 52-weeks and participants will undergo metabolic characterization at baseline, 12-24-, 36- and 52-weeks. The primary outcome of pancreatic beta-cell function will be assessed by Insulin Secretion-Sensitivity Index-2 (ISSI-2). Additional metabolic measures will include insulin resistance and glucose homeostasis.<h4>Discussion</h4>TRE may represent an adjunct therapeutic approach for improving the metabolic profile of overweight/obese individuals with T2DM while also providing the capacity for modification of its underlying pathophysiology. This

Intermittent Fasting: A Metabolically Focused Therapeutic Strategy for Obesity

●●●○○ Nutrients·2026· 3 Zitationen· cc by Original ↗
Abstract

The global prevalence of obesity continues to rise and is a significant risk factor for the onset and progression of cardiovascular diseases. Despite the development of new pharmacological therapies, novel strategies are being explored to mitigate the impact of this disease. Intermittent fasting (IF) is a nutritional intervention that has gained popularity and shows potential as an innovative approach to weight management. This study aims to compile scientific evidence on various aspects of fasting, including its physiological effects, the molecular and thermogenic mechanisms involved, and recommendations regarding nutritional strategies during the refeeding period within the eating window. We conducted a narrative review, analyzing evidence available from PubMed/MEDLINE based on studies related to intermittent fasting, thermogenesis, and their associated outcomes. Our results demonstrate the existence of three commonly used IF protocols: alternate day fasting (ADF), periodic fasting (PF), and time-restricted eating (TRE). In addition to its effects on weight loss, IF has demonstrated notable benefits for cardiovascular health, oxidative stress, and metabolic function. Moreover, the interaction between the central nervous system and brown adipose tissue provides an alternative mechanism for the molecular regulation of thermogenesis. Nutritional patterns adopted during intermittent fasting play a crucial role in optimizing outcomes, with particular emphasis on the intake of pr

Quellen aus Europe PMC, ausschließlich CC0, CC BY oder CC BY-SA. Der redaktionelle Text ist eine eigene Formulierung, keine Übernahme aus den Originalarbeiten.

Medizinische Prüfung: Dr. med. Anna Reuter, Fachärztin für Innere Medizin, 18. Juni 2026.